Amarin (AMRN) announces $100M in non-equity financing with an investment fund managed by...
Thursday, December 6, 2012, 4:21 PM ETAmarin (AMRN) announces $100M in non-equity financing with an investment fund managed by Pharmakon Advisors, and that it's continuing preparations to commercialize Vascepa capsules by hiring a sales force in the United States. Payments under this hybrid debt-like instrument are expected to be made over a 3.5-year period commencing in November 2013 and to continue through early 2017. Shares -21% AH.
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles